A Study of Endocrine Profile in Premenopausal Women With Hirsutism

    January 2014 in “ Journal of Integrated Health Sciences ”
    J. M. Som, JLakhani Om, RC Raval
    TLDR Obesity is strongly linked to the severity of hirsutism in women.
    The study investigated the endocrine profile of 44 premenopausal women with hirsutism, defined by a Modified Ferriman-Gallwey score of ≥ 8. The average age of participants was 20-29 years, with symptoms persisting for 3 years. The most common site for hair growth was the upper lip, and hair loss and menstrual irregularity were frequently observed. Obesity was significantly correlated with the severity of hirsutism, while no correlation was found between hirsutism severity and endocrine test results, including testosterone and insulin levels. Idiopathic hirsutism was the most common diagnosis, followed by polycystic ovary syndrome (PCOS), with elevated serum testosterone and LH/FSH ratio noted in the PCOS group. The study concluded that obesity was strongly related to hirsutism severity, independent of other endocrine parameters.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 27 results

      community AA and Hirsutism but T levels are normal

      in Female  6 upvotes 4 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Finasteride 5mg & Spironolactone 100mg

      in Female  2 upvotes 1 year ago
      A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  107 upvotes 4 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  121 upvotes 1 year ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  12 upvotes 1 year ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    1 / 1 results